<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" xmlns:NCBITaxon="http://purl.obolibrary.org/obo/NCBITaxon#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:obo="http://purl.obolibrary.org/obo/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:ncbitaxon="http://purl.obolibrary.org/obo/ncbitaxon#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>                                                          RESEARCH ARTICLE <br />  <br />  <br />                                                           An Essential Signal Peptide Peptidase <br />                                                           Identified RNAi Screen Serine <br />                                                           Peptidases <span id='am-25' about='obo:NCBITaxon_5690' typeof='owl:Thing obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_33682 obo:NCBITaxon_5654 obo:NCBITaxon_2759 obo:NCBITaxon_5653'><span id='am-26' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-27' property="rdfs:label" content="Trypanosoma" datatype="xsd:string"></span><span id='am-28' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-29'  ></span>Trypanosoma</span> brucei <br />                                                           Catherine X. Moss1*, Elaine Brown1, Alana Hamilton1, Pieter Van der Veken2, <br />                                                           Koen Augustyns2, Jeremy C. Mottram1 <br />                                                           1 Wellcome Trust Centre Molecular Parasitology, Institute Infection, Immunity Inflammation, <br />                                                           College Medical, Veterinary Life Sciences, University Glasgow, Glasgow, United <span id='am-100' about='obo:NCBITaxon_kingdom' typeof='owl:Thing NCBITaxon:_taxonomic_rank'><span id='am-101' property="rdfs:label" content="kingdom" datatype="xsd:string"></span><span id='am-102' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>Kingdom</span>, <br />                                                           2 Medicinal Chemistry (UAMC), Department Pharmaceutical Sciences, University Antwerp, Wilrijk, <br />                                                           Antwerp, Belgium <br />        a11111 <br />                                                           * catherinexmoss@gmail.com <br />  <br />  <br />  <br />  <br />                                                           Abstract <br />                                                           The serine peptidases <span id='am-30' about='obo:NCBITaxon_5691' typeof='owl:Thing obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_39700 obo:NCBITaxon_33682 obo:NCBITaxon_5654 obo:NCBITaxon_5690 obo:NCBITaxon_2759 obo:NCBITaxon_5653'><span id='am-31' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-32' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-33'  ></span><span id='am-34' property="oboInOwl:hasRelatedSynonym" content="Trypanosoma brucei subgroup" datatype="xsd:string"></span><span id='am-35' property="rdfs:label" content="Trypanosoma brucei" datatype="xsd:string"></span><span id='am-36' property="oboInOwl:hasRelatedSynonym" content="Trypanosoma (Trypanozoon) brucei" datatype="xsd:string"></span>Trypanosoma brucei</span> viewed potential drug targets. <br />     OPEN ACCESS <br />                                                           In particular, S9 prolyl oligopeptidase <span id='am-68' about='obo:NCBITaxon_subfamily' typeof='owl:Thing NCBITaxon:_taxonomic_rank'><span id='am-69' property="rdfs:label" content="subfamily" datatype="xsd:string"></span><span id='am-70' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>subfamily</span> thought good avenue drug <br /> Citation: Moss CX, Brown E, Hamilton A, Van der           discovery. <span id='am-74' about='obo:NCBITaxon_169495' typeof='owl:Thing obo:NCBITaxon_33340 obo:NCBITaxon_33213 obo:NCBITaxon_169440 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_7147 obo:NCBITaxon_43733 obo:NCBITaxon_33154 obo:NCBITaxon_43738 obo:NCBITaxon_480117 obo:NCBITaxon_33317 obo:NCBITaxon_169449 obo:NCBITaxon_480118 obo:NCBITaxon_2759 obo:NCBITaxon_6072 obo:NCBITaxon_6960 obo:NCBITaxon_43750 obo:NCBITaxon_33208 obo:NCBITaxon_85512 obo:NCBITaxon_197562 obo:NCBITaxon_197563 obo:NCBITaxon_7203 obo:NCBITaxon_6656 obo:NCBITaxon_7496 obo:NCBITaxon_1206794 obo:NCBITaxon_88770 obo:NCBITaxon_33392 obo:NCBITaxon_169455 obo:NCBITaxon_50557 obo:NCBITaxon_43741'><span id='am-75' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-76' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-77' property="rdfs:label" content="This" datatype="xsd:string"></span><span id='am-78'  ></span>This</span> based finding S9 peptidases secreted active in <br /> Veken P, Augustyns K, Mottram JC (2015) An <br />                                                           mammalian bloodstream, <span id='am-71' about='obo:NCBITaxon_class' typeof='owl:Thing NCBITaxon:_taxonomic_rank'><span id='am-72' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-73' property="rdfs:label" content="class" datatype="xsd:string"></span>class</span> enzyme drugs have <br /> Essential Signal Peptide Peptidase Identified an <br /> RNAi Screen Serine Peptidases Trypanosoma           successfully developed. We collated list serine peptidases T. brucei, identify- <br /> brucei. PLoS ONE 10(3): e0123241. doi:10.1371/            ing 20 serine peptidase genes, S9 peptidases. We screened 20 serine <br /> journal.pone.0123241                                      peptidases RNAi determine which, any, essential bloodstream form T. brucei <br /> Academic Editor: Mauricio Martins Rodrigues,              survival. All S9 serine peptidases dispensable parasite survival vitro, when <br /> Federal University S&#227;o Paulo, BRAZIL                   pairs similar genes, coding oligopeptidase B prolyl oligopeptidase, targeted si- <br /> Received: January 15, 2015                                multaneously. We effect parasite survival animal host S9 <br /> Accepted: March 1, 2015                                   peptidases oligopeptidase B, prolyl oligopeptidase dipeptidyl peptidase 8 targeted. <br />                                                           The serine peptidase emerge RNAi screen essential putative <br /> Published: March 27, 2015 <br />                                                           type-I signal peptide peptidase (SPP1). This gene essential parasite survival in <br /> Copyright: &#169; 2015 Moss et al. This open <br />                                                           vitro vivo. The growth defect conferred RNAi depletion SPP1 rescued by <br /> access article distributed terms the <br /> Creative Commons Attribution License, permits       expression functional peptidase RNAi resistant SPP1 gene. However, expres- <br /> unrestricted use, distribution, reproduction   sion catalytically inactive SPP1 unable rescue cells SPP1 depleted phe- <br /> medium, provided original author source       notype, demonstrating SPP1 serine peptidase activity necessary T. <br /> credited. <br />                                                           brucei survival. <br /> <span id='am-103' about='obo:NCBITaxon_1369087' typeof='obo:NCBITaxon_37567 owl:Thing obo:NCBITaxon_33340 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_85604 obo:NCBITaxon_104431 obo:NCBITaxon_33154 obo:NCBITaxon_37570 obo:NCBITaxon_41191 obo:NCBITaxon_33317 obo:NCBITaxon_2759 obo:NCBITaxon_6072 obo:NCBITaxon_6960 obo:NCBITaxon_33208 obo:NCBITaxon_41196 obo:NCBITaxon_197562 obo:NCBITaxon_85512 obo:NCBITaxon_197563 obo:NCBITaxon_95182 obo:NCBITaxon_41197 obo:NCBITaxon_6656 obo:NCBITaxon_7496 obo:NCBITaxon_7088 obo:NCBITaxon_1206794 obo:NCBITaxon_88770 obo:NCBITaxon_7100 obo:NCBITaxon_33392 obo:NCBITaxon_50557'><span id='am-104'  ></span><span id='am-105' property="rdfs:label" content="Data" datatype="xsd:string"></span><span id='am-106' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-107' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span>Data</span> Availability Statement: All relevant data are <br /> within paper Supporting Information files. <br />  <br /> Funding: The Wellcome Trust Grant WT091117MA <br /> www.wellcome.ac.uk. The Wellcome Trust Core <br /> Funding Grant 085349 www.wellcome.ac.uk. The <br /> Medical Research Council Grant G0700127 (to JCM)          Introduction <br /> www.mrc.ac.uk. CXM supported Beit <br />                                                           Human African Trypanosomiasis (HAT) disease developing world fatal left <br /> Memorial Fellowship Medical Research. The <br /> funders role study design, data collection <br />                                                           untreated. Following strong collaborative efforts combat disease number new <br /> and analysis, decision publish, preparation      cases reported dropped 17,500 annually [1], actual case-load likely be <br /> the manuscript.                                           times reported figure. While improved situation encouraging, is <br />  <br />  <br />  <br /> PLOS ONE | DOI:10.1371/journal.pone.0123241 March 27, 2015                                                                                                     1 / 15 <br />                                                                                           An Essential Signal Peptide Peptidase Trypanosoma brucei <br />  <br />  <br />  <br /> Competing Interests: The authors declared   pressing need new chemotherapies HAT. The current set 4 licenced drugs <br /> that competing interests exist.               (pentamidine, suramin, melarsoprol, eflornithine) problems toxicity, mode ad- <br />                                                  ministration, efficacy. Moreover reduction HAT prevalence raised concerns of <br />                                                  disease resurgence complacency causes withdrawal resources. <br />                                                      The publication genome Trypanosome brucei [2] marked leap forward the <br />                                                  quest novel drug targets parasite. A combination genomic data together <br />                                                  systems induce loss-of-function using RNA interference T. brucei led explosion <br />                                                  studies highlighting specific genes important parasite potential <br />                                                  drug targets, reviewed [3]. Most recently, high throughput studies screened large co- <br />                                                  horts genes potential drug targets, taking entire chromosome [4], gene <span id='am-11' about='obo:NCBITaxon_family' typeof='owl:Thing NCBITaxon:_taxonomic_rank'><span id='am-12' property="rdfs:label" content="family" datatype="xsd:string"></span><span id='am-13' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>family</span> [5] <br />                                                  entire genome [6]. <br />                                                      We undertaken RNAi study scrutinise biochemically related set of <br />                                                  genes, serine peptidases, potential drug targets. The serine peptidases deemed suit- <br />                                                  able drug target candidates appear important virulence factors T. brucei <br />                                                  <span id='am-20' about='obo:NCBITaxon_5693' typeof='owl:Thing obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_33682 obo:NCBITaxon_5654 obo:NCBITaxon_5690 obo:NCBITaxon_2759 obo:NCBITaxon_47570 obo:NCBITaxon_5653'><span id='am-21' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-22' property="rdfs:label" content="Trypanosoma cruzi" datatype="xsd:string"></span><span id='am-23'  ></span><span id='am-24' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>Trypanosoma cruzi</span> [7&#8211;9]. Oligopeptidase B (OPB) released bloodstream from <br />                                                  <span id='am-37' about='obo:NCBITaxon_5697' typeof='owl:Thing obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_39700 obo:NCBITaxon_33682 obo:NCBITaxon_5654 obo:NCBITaxon_5690 obo:NCBITaxon_2759 obo:NCBITaxon_5653'><span id='am-38' property="rdfs:label" content="Trypanosoma evansi" datatype="xsd:string"></span><span id='am-39' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-40'  ></span><span id='am-41' property="oboInOwl:hasRelatedSynonym" content="Trypanosoma (Trypanozoon) evansi" datatype="xsd:string"></span><span id='am-42' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>Trypanosoma evansi</span> T. brucei where, effective endogenous inhibitors, <br />                                                  proteolytically inactivates host peptide hormones [10, 11]. In addition likely involve- <br />                                                  ment host-parasite interactions, evidence suggesting serine peptidases drug <br />                                                  targets. Two classes serine peptidase inhibitor anti-trypanosomal activity T. <br />                                                  brucei [12] currently used therapeutic drugs suramin, pentamidine diminiazine in- <br />                                                  hibit T. brucei OPB. The mode action drugs necessarily serine peptidases, <br />                                                  serine peptidases 28 genes linked suramin action genome <br />                                                  scale RNAi screen [13]. Nevertheless, sufficient evidence T. brucei serine pepti- <br />                                                  dases worth investigating potential drug targets. Importantly, peptidases biochemi- <br />                                                  cally tractable likely druggable. Amongst examples peptidases that <br />                                                  successfully developed drug targets serine peptidase DPP IV. Human DPP <br />                                                  IV target inhibitors licensed treatment type 2 diabetes [14]. <br />                                                      Here, conducted medium-throughput investigation potential novel drug tar- <br />                                                  gets, comprising serine peptidases T. brucei. From 20 putative serine peptidases T. <br />                                                  brucei essential parasite survival, putative type I-like <br />                                                  signal peptidase. <br />  <br />                                                  Materials Methods <br />                                                  Ethics statement <br />                                                  All animal procedures undertaken adherence experimental guidelines proce- <br />                                                  dures approved The Home Office UK government. All work covered Home <br />                                                  Office Project Licence PPL60/4442 entitled &#8220;Molecular Genetics Trypanosomes Leish- <br />                                                  mania&quot;. Mice euthanised carbon dioxide inhalation, accordance Animals <br />                                                  (Scientific Procedures) Act 1986. <br />  <br />                                                  Bioinformatics <br />                                                  All T. brucei TREU 927 predicted protein sequences downloaded TriTrypDB. To <br />                                                  search predicted serine peptidases based overall sequence homology, protein se- <br />                                                  quences used BLASTP search <span id='am-1' about='obo:NCBITaxon_57420' typeof='owl:Thing obo:NCBITaxon_33213 obo:NCBITaxon_8936 obo:NCBITaxon_1329799 obo:NCBITaxon_1 obo:NCBITaxon_32523 obo:NCBITaxon_131567 obo:NCBITaxon_32524 obo:NCBITaxon_436489 obo:NCBITaxon_117570 obo:NCBITaxon_89593 obo:NCBITaxon_7742 obo:NCBITaxon_117571 obo:NCBITaxon_33154 obo:NCBITaxon_8782 obo:NCBITaxon_436486 obo:NCBITaxon_1338369 obo:NCBITaxon_8287 obo:NCBITaxon_2759 obo:NCBITaxon_8492 obo:NCBITaxon_6072 obo:NCBITaxon_33511 obo:NCBITaxon_33208 obo:NCBITaxon_7711 obo:NCBITaxon_8825 obo:NCBITaxon_7776 obo:NCBITaxon_57386 obo:NCBITaxon_436492 obo:NCBITaxon_32561 obo:NCBITaxon_8457 obo:NCBITaxon_436491'><span id='am-2' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-3' property="rdfs:label" content="Merops" datatype="xsd:string"></span><span id='am-4'  ></span><span id='am-5' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>MEROPS</span> peptidase database [15]. This gen- <br />                                                  erated list 29 potential serine peptidases. Of these, 16 annotated serine <br />                                                  peptidases GeneDB time searching. The remaining 13 sequences used a <br />                                                  BLASTP search closest relatives non-redundant protein database. Of these, 10 were <br />                                                  closely related families hydrolases, esterases lipases, <br />  <br />  <br />  <br /> PLOS ONE | DOI:10.1371/journal.pone.0123241 March 27, 2015                                                                                      2 / 15 <br />                                                                                   An Essential Signal Peptide Peptidase Trypanosoma brucei <br />  <br />  <br />  <br />                                          unlikely peptidases. Three sequences (Tb927.8.5760, Tb927.9.12980, <br />                                          Tb927.6.1810), however, sequence homology serine peptidases. To de- <br />                                          termine active serine peptidases pseudopeptidases, searched ac- <br />                                          tive site residues. Serine peptidases possess nucleophilic serine residue, forms of <br />                                          catalytic dyad triad. The genes Tb927.8.5760 Tb927.6.1810 code sequences contain- <br />                                          ing catalytic residues serine, aspartic acid, histidine, catalytic triad possessed S9 <br />                                          family serine peptidases. So, based sequence homology presence catalytic <br />                                          triad, Tb927.8.5760 Tb927.6.1810 appear S9 serine peptidases. <br />                                              In addition identifying <span id='am-113' about='obo:NCBITaxon_32644' typeof='owl:Thing obo:NCBITaxon_12908 obo:NCBITaxon_1'><span id='am-114' property="oboInOwl:hasRelatedSynonym" content="unclassified sequence" datatype="xsd:string"></span><span id='am-115' property="oboInOwl:hasRelatedSynonym" content="other" datatype="xsd:string"></span><span id='am-116'  ></span><span id='am-117' property="oboInOwl:hasRelatedSynonym" content="none" datatype="xsd:string"></span><span id='am-118' property="oboInOwl:hasRelatedSynonym" content="unspecified" datatype="xsd:string"></span><span id='am-119' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-120' property="rdfs:label" content="unidentified" datatype="xsd:string"></span><span id='am-121' property="oboInOwl:hasRelatedSynonym" content="unidentified organism" datatype="xsd:string"></span><span id='am-122' property="oboInOwl:hasRelatedSynonym" content="not shown" datatype="xsd:string"></span><span id='am-123' property="oboInOwl:hasRelatedSynonym" content="sonstige nucleic acid" datatype="xsd:string"></span><span id='am-124' property="oboInOwl:hasRelatedSynonym" content="unknwon" datatype="xsd:string"></span><span id='am-125' property="oboInOwl:hasRelatedSynonym" content="unknown" datatype="xsd:string"></span><span id='am-126' property="oboInOwl:hasRelatedSynonym" content="miscellaneous nucleic acid" datatype="xsd:string"></span><span id='am-127' property="oboInOwl:hasRelatedSynonym" content="not specified" datatype="xsd:string"></span><span id='am-128' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-129' property="oboInOwl:hasRelatedSynonym" content="unknown organism" datatype="xsd:string"></span>unidentified</span> serine peptidases, examined 9 genes an- <br />                                          notated serine peptidases GeneDB, retrieved BLASTP search against <br />                                          MEROPS database. When individual protein sequences used BLASTP search of <br />                                          MEROPS database, sequences peptidases families <br />                                          serine peptidase family, unlikely peptidases (Tb927.5.1870, <br />                                          Tb927.10.3520, Tb927.11.3870, Tb927.11.8350, Tb927.2.5980, Tb927.2.3030). The GeneDB an- <br />                                          notation genes altered remove putative serine peptidases. <br />                                          Three genes annotated serine peptidases appear code pseudopeptidases, they <br />                                          bear sequence homology serine peptidase families S51 (Tb927.11.12610) S54 <br />                                          (Tb927.9.8260 Tb927.8.1810), lack designated active site residues family. <br />                                          Elsewhere, predicted rhomboid-like gene (Tb927.2.2500) identified contains <br />                                          S54 family active site residues [16] added list serine peptidases (Table 1). <br />  <br />                                          Cell culture <br />                                          The T. brucei bloodstream form 2T1 cell line [17] gift David Horn (LSHTM, Lon- <br />                                          don) cultured HMI-11 (HMI-9 (Gibco), 10% v/v FCS (Gibco,10270), Penicillin <br />                                          (20Uml-1)/Streptomycin (20 &#956;gml-1) (Sigma)), described previously [17]. Selective drugs <br />                                          used following concentrations appropriate: 2 &#956;gml-1 puromycin, 2.5 &#956;gml-1 <br />                                          phleomycin (InvivoGen), 5 &#956;gml-1 hygromycin B (Calbiochem) 10 &#956;gml-1 blasticidin <br />                                          (InvivoGen). <br />  <br />                                          Plasmid construction <br />                                          An RNAi target fragment 400&#8211;600 bp identified gene using RNAit target selec- <br />                                          tion software [18]. Target fragments amplified T. brucei genomic DNA forward <br />                                          reverse primers including AttB1 AttB2 sites respectively (S1 Table). The constructs <br />                                          used RNA interference based tetracycline inducible stem loop RNAi vector <br />                                          pRPAiSL[17]. The plasmid modified incorporate pairs AttP1 AttP2 se- <br />                                          quences, opposing directions, flanking toxic ccdB gene [5]. Two copies AttB1/ <br />                                          AttB2 tagged RNAi target fragment incorporated opposing directions plasmid <br />                                          single reaction using BP recombinase. Recombination RNAi fragments vec- <br />                                          <span id='am-95' about='obo:NCBITaxon_172918' typeof='owl:Thing obo:NCBITaxon_186623 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_186627 obo:NCBITaxon_186626 obo:NCBITaxon_131567 obo:NCBITaxon_186625 obo:NCBITaxon_117570 obo:NCBITaxon_89593 obo:NCBITaxon_7742 obo:NCBITaxon_117571 obo:NCBITaxon_33154 obo:NCBITaxon_7952 obo:NCBITaxon_7953 obo:NCBITaxon_2759 obo:NCBITaxon_6072 obo:NCBITaxon_33511 obo:NCBITaxon_32519 obo:NCBITaxon_30727 obo:NCBITaxon_33208 obo:NCBITaxon_7711 obo:NCBITaxon_186634 obo:NCBITaxon_1489341 obo:NCBITaxon_7776 obo:NCBITaxon_7898 obo:NCBITaxon_41665 obo:NCBITaxon_32443'><span id='am-96' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-97' property="rdfs:label" content="Tor" datatype="xsd:string"></span><span id='am-98' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-99'  ></span>tor</span> tested using ccdB susceptible strain E. coli grow plasmid. <br />                                             Recoded SPP1 synthesised Dundee Cell Products. The recoded SPPI sequence <br />                                          (SPPIR) codes amino acid sequence SPPI shares 76.3% identity (S1 <br />                                          Fig.). All segments identity SPPI SPPIR 20 base pairs long. SPPIR <br />                                          inserted plasmid pGL2243 using XbaI BamHI restriction sites, generating <br />                                          pGL2308. This plasmid designed constitutively express SPPI tubulin locus, with <br />                                          addition C-terminal 6x HA tag (Jones, NG, unpublished). To express catalytically inac- <br />                                          tive SPPI, active site serine (Ser84) changed <span id='am-6' about='obo:NCBITaxon_3846' typeof='owl:Thing obo:NCBITaxon_78536 obo:NCBITaxon_3814 obo:NCBITaxon_1 obo:NCBITaxon_72025 obo:NCBITaxon_131567 obo:NCBITaxon_3803 obo:NCBITaxon_3398 obo:NCBITaxon_1437183 obo:NCBITaxon_33090 obo:NCBITaxon_163735 obo:NCBITaxon_91827 obo:NCBITaxon_131221 obo:NCBITaxon_71240 obo:NCBITaxon_58024 obo:NCBITaxon_1437201 obo:NCBITaxon_58023 obo:NCBITaxon_91835 obo:NCBITaxon_2759 obo:NCBITaxon_35493 obo:NCBITaxon_71275 obo:NCBITaxon_3193'><span id='am-7' property="rdfs:label" content="Glycine" datatype="xsd:string"></span><span id='am-8'  ></span><span id='am-9' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-10' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>glycine</span> mutating pGL2308, carrying <br />                                          coding sequence SPP1, using site directed mutagenic PCR oligonucleotides <br />                                          OL4309 OL4310, generating plasmid pGL2319. <br />  <br />  <br />  <br /> PLOS ONE | DOI:10.1371/journal.pone.0123241 March 27, 2015                                                                              3 / 15 <br />                                                                                         An Essential Signal Peptide Peptidase Trypanosoma brucei <br />  <br />  <br />  <br /> Table 1. Comparison serine peptidase RNAi screen RIT-seq phenotypes. <br />  <br /> Family                        Gene ID          Gene                                    RIT-seq phenotype&#8224;            RNAi cell line <br />                                                                                                                           phenotype <br /> S8 Subtilisin                 Tb927.3.4230     subtilisin-like serine peptidase             Normal                 Normal <br />                               Tb927.11.3780*   subtilisin-like serine peptidase             Abnormal BSF 6d        Normal <br />                                                                                             PCF <br /> S9                            Tb927.11.12850   oligopeptidase B                             Normal                 Normal <br /> Prolyloligopeptidase          Tb927.10.8020    prolyl oligopeptidase, putative              Normal                 Normal <br />                               Tb927.5.4300     prolyl oligopeptidase-like                   Normal                 Normal <br />                               Tb927.10.6940    dipeptidyl peptidase                         As Tb927.10.6970          Normal <br />                               * <br />                               Tb927.10.6970    dipeptidyl peptidase                         Normal                 Normal <br />                               * <br />                               Tb927.7.4940 *   oligopeptidase B-like                        Abnormal BSF 3d 6d     Normal <br />                               Tb11.v5.0175 *   oligopeptidase B-like                        As Tb927.7.4940           Normal <br />                               Tb927.9.10970    BEM46-like                                   Normal                 Normal <br />                               Tb927.1.4780     S9D serine peptidase                         Abnormal diff BSF          Normal <br />                               Tb927.8.5760     hypothetical protein                         Abnormal BSF 6d            Normal <br />                               Tb927.6.1810     hypothetical protein                         Normal                 Normal <br /> S10 Carboxypeptidase          Tb927.10.1030    serine carboxypeptidase III precursor        Normal                 Normal <br />                               Tb927.10.1040    serine carboxypeptidase III precursor        As Tb927.10.1030          Normal <br />                               Tb927.10.1050    serine carboxypeptidase III precursor        As Tb927.10.1030          Normal <br /> S26 Signal peptidase          Tb927.10.4590    mitochondrial inner membrane signal          Normal                 Normal <br />                                                peptidase <br />                               Tb927.5.3220     signal peptidase type I                      Normal                 Abnormal <br /> S54 Rhomboid                  Tb927.2.2500     hypothetical protein                         Normal                 Normal <br /> S59 Nucleoporin               Tb927.11.980     nucleoporin                                  Normal                 Normal <br />  <br /> * Identical coding sequences <br /> &#8224; <br />     3d, 6d denote 3 6 days induction RNAi <br />  <br /> doi:10.1371/journal.pone.0123241.t001 <br />  <br />  <br />  <br />  <br />                                                 Cell lines transfection <br />                                                 RNAi <span id='am-108' about='obo:NCBITaxon_36549' typeof='owl:Thing obo:NCBITaxon_1 obo:NCBITaxon_28384'><span id='am-109' property="oboInOwl:hasDbXref" content="GC_ID:11" datatype="xsd:string"></span><span id='am-110' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-111' property="rdfs:label" content="plasmids" datatype="xsd:string"></span><span id='am-112' property="oboInOwl:hasAlternativeId" content="NCBITaxon:2435" datatype="xsd:string"></span>plasmids</span> (5&#956;g) digested AscI linearise integration cassette, was <br />                                                 purified QiagenPCR purification kit, ethanol precipitated resuspended 10&#956;l <br />                                                 sterile water. 2T1 cells transfected using Nucleofector instrument (Lonza), the <br />                                                 X01 setting, using Amaxa Human T cell Nucleofector kit (Lonza). Cells integrated <br />                                                 RNAi cassette selected using hygromycin (2.5&#956;g ml-1). Clonal cell lines generated in <br />                                                 step tested puromycin sensitivity, puromycin sensitive clones retained <br />                                                 analysis. To determine RNAi phenotype, cells induced 1&#956;g ml-1 <span id='am-90' about='obo:NCBITaxon_1310384' typeof='owl:Thing obo:NCBITaxon_33208 obo:NCBITaxon_33213 obo:NCBITaxon_83136 obo:NCBITaxon_1 obo:NCBITaxon_83139 obo:NCBITaxon_131567 obo:NCBITaxon_6854 obo:NCBITaxon_426515 obo:NCBITaxon_6843 obo:NCBITaxon_426501 obo:NCBITaxon_33154 obo:NCBITaxon_6933 obo:NCBITaxon_6656 obo:NCBITaxon_70332 obo:NCBITaxon_6946 obo:NCBITaxon_1206794 obo:NCBITaxon_88770 obo:NCBITaxon_70320 obo:NCBITaxon_6947 obo:NCBITaxon_33317 obo:NCBITaxon_2759 obo:NCBITaxon_6072'><span id='am-91' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-92' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-93'  ></span><span id='am-94' property="rdfs:label" content="Tetra" datatype="xsd:string"></span>tetra</span>- <br />                                                 cycline cell density 1 x 105ml-1 counted 24 hour intervals 5 days. Two individ- <br />                                                 ual clonal cell lines analysed target gene. For expression recoded SPP1, 5&#956;g <br />                                                 pGL2308 pGL2319 (inactive mutant) digested AscI, transfected the <br />                                                 RNAi plasmids (above). Cells integrated recoded SPP1 expression cassette se- <br />                                                 lected using blasticidin (10&#956;gml-1). Blasticidin resistant clones subjected second <br />                                                 round selection tetracycline induce RNAi. Clones survived 3 days pres- <br />                                                 ence 1&#956;gml-1 tetracycline tested expression SPP1 Western blot anti- <br />                                                 HA antibody (Roche). <br />  <br />  <br />  <br />  <br /> PLOS ONE | DOI:10.1371/journal.pone.0123241 March 27, 2015                                                                                    4 / 15 <br />                                                                                 An Essential Signal Peptide Peptidase Trypanosoma brucei <br />  <br />  <br />  <br />                                          Activity DPP8 inhibitors <br />                                          The following compounds target human DPP8 DPP9 (and cases DPP IV), <br />                                          synthesised described previously: UAMC-00374, UAMC-00662 [19]; UAMC-00491 <br />                                          [20]; UAMC-00691, UAMC-00701, UAMC-00726 [21]; vildagliptin [22]; UAMC-0800 [23]. <br />                                          These stored DMSO -20&#176;C diluted immediately prior use maxi- <br />                                          mum DMSO concentration assay did exceed 1%. The IC50 inhibitory compounds <br />                                          recombinant TbDPP8 determined using fluorometric assay 96-well flat- <br />                                          bottomed plate 50 mM Tris/HCl pH 7.5, 100 mM NaCl. Compounds doubly diluted to <br />                                          final concentrations ranging 100 &#956;M Tb-DPP8 added assay at <br />                                          indicated concentrations. The hydrolysis fluorogenic substrate H-Gly-Pro-AMC <br />                                          (Bachem) measured EnVision plate reader using excitation emission wave- <br />                                          lengths 355 nm ad 460 nm respectively. Fluorescence plotted compound concen- <br />                                          tration IC50 values calculated using GraFit (Erithicus). <br />                                             To test effect compounds parasites, inhibitory compounds doubly diluted in <br />                                          HMI-11 250 &#956;M (final inhibitor concentration) 96-well plate (Costar). Bloodstream <br />                                          form T. brucei 427 added density 1 x 105 cells ml-1in 200 &#956;l HMI-11 96-well <br />                                          plate. Parasites incubated compounds 48 hours, 0.1 volumes <span id='am-85' about='obo:NCBITaxon_1416571' typeof='owl:Thing obo:NCBITaxon_33208 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_116706 obo:NCBITaxon_6804 obo:NCBITaxon_131567 obo:NCBITaxon_116704 obo:NCBITaxon_197562 obo:NCBITaxon_197563 obo:NCBITaxon_33154 obo:NCBITaxon_72041 obo:NCBITaxon_6681 obo:NCBITaxon_6656 obo:NCBITaxon_6692 obo:NCBITaxon_6682 obo:NCBITaxon_6657 obo:NCBITaxon_1206794 obo:NCBITaxon_6683 obo:NCBITaxon_88770 obo:NCBITaxon_6752 obo:NCBITaxon_33317 obo:NCBITaxon_2759 obo:NCBITaxon_553065 obo:NCBITaxon_6072'><span id='am-86' property="rdfs:label" content="Ala" datatype="xsd:string"></span><span id='am-87' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-88' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-89'  ></span>Ala</span>- <br />                                          mar Blue (0.49 mM resazurin PBS) added. After incubation 24 hours, fluo- <br />                                          rescence read &#955;excitation 485 nm &#955;emission 620 nm Envision Plate Reader (Perkin <br />                                          Elmer). The EC50 calculated using GraFit software. <br />  <br />                                          Quantitative PCR <br />                                          Total RNA purified 2&#8211;5 x 107 T. brucei cells using RNeasy miniprep kit (Qiagen) <br />                                          according manufacturer&#8217;s instructions. Genomic DNA removed RQ1 DNaseI (Pro- <br />                                          mega) strand cDNA synthesised using Superscript III (Invitrogen) according man- <br />                                          ufacturer&#8217;s instructions. Quantitative PCR 7500 Real-time PCR system <br />                                          (Applied Biosystems) 25 &#956;l reaction contained approximately 0.5 &#956;g cDNA, 7.5 pmol <br />                                          primer, Sybr Green PCR Master Mix (Applied Biosystems). The primers used for <br />                                          real time PCR reactions listed S2 Table. The temperature cycling regime fol- <br />                                          lows: 50&#176;C 2 min, 95&#176;C 10 min, followed 40 cycles (95&#176;C 15 sec 60&#176;C 1 <br />                                          min). Relative quantification using comparative Ct method (2-&#916;&#916;CT) the <br />                                          7500 System SDS software. <br />  <br />                                          In vivo RNAi <br />                                          Groups ICR mice infected 5 x 105 T. brucei RNAi cells intraperitoneal in- <br />                                          jection. RNAi induced mice group giving mice water containing 0.2g/ <br />                                          L doxycycline 5% sucrose. Parasitaemia checked daily diluting tail vein blood in <br />                                          0.83% ammonium chloride counting parasites using haemocytometer. <br />  <br />                                          Results <br />                                          Identification serine peptidases <br />                                          We 20 individual genes representing serine peptidases families T. brucei <br />                                          genome (Table 1). Notably, representatives largest peptidase family, S1 (chymotryp- <br />                                          sin/trypsin) peptidases, T. brucei, trypanosomatids [15]. <br />                                          The abundant serine peptidase family T.brucei S9 prolyl oligopeptidase-like fami- <br />                                          ly (reviewed [23]), members present genome. This family includes oligopep- <br />                                          tidaseB, peptidase plants, bacteria kinetoplastids. There genes <br />  <br />  <br />  <br /> PLOS ONE | DOI:10.1371/journal.pone.0123241 March 27, 2015                                                                            5 / 15 <br />                                                                                  An Essential Signal Peptide Peptidase Trypanosoma brucei <br />  <br />  <br />  <br />                                          encoding oligopeptidase B like peptidases T. brucei (Tb927.11.12850, Tb927.7.4940, and <br />                                          Tb11.v5.0175), identical gene sequences. There identical <br />                                          tandem copies dipeptidyl peptidase 8 like gene (Tb927.10.6940 Tb927.10.6970), which <br />                                          member S9 family. Other S9 peptidases include prolyl oligopeptidase-like <br />                                          genes (Tb927.10.8020 Tb927.5.4300), BEM46 like gene (Tb927.9.10970), glutamyl <br />                                          endopeptidase (Tb927.1.4780). In addition previously indentified S9 peptidases, we <br />                                          identified new S9 family members (Tb927.8.5760 Tb927.6.1810) performing a <br />                                          BLAST search MEROPS peptidase database [15] using entire T. brucei genome. The <br />                                          genome contains subtilisin (S8 family) genes (Tb927.3.4230 Tb11.02.1280), three <br />                                          carboxypeptidase (S10 family) genes (Tb927.10.1030, Tb927.10.1040, Tb927.10.1050), sig- <br />                                          nal peptidase (S26 family) genes (Tb927.10.4590 Tb927.5.3220), nucleoporin (S59 <br />                                          family) gene (Tb11.03.0140) rhomboid (S54 family) gene (Tb927.2.2500). We also <br />                                          identified potential pseudopeptidases, sequence similarity lack predicted <br />                                          active site residues: S9 BEM46-like pseudopeptidase (Tb927.9.12980), S54 rhomboid- <br />                                          like pseudopeptidases (Tb927.9.8260 Tb927.8.1810) S51 dipeptidase E-like pseudo- <br />                                          peptidase (Tb927.11.12610). <br />  <br />  <br />                                          RNAi screen <br />                                          To determine parasite&#8217;s requirement individual peptidases, RNAi used knock <br />                                          transcript levels. We chose use inducible stem loop RNAi vector, inserted op- <br />                                          timised tagged ribosomal locus [17] vector shown efficient re- <br />                                          producible knock target genes [24]. The stem loop vector pRPaiSL modified <br />                                          include AttP1 AttP2 recombination sites, enabling higher throughput cloning RNAi <br />                                          target sequences [5]. After induction RNAi tetracycline, cell lines monitored for <br />                                          days growth defects. RNAi knock-down peptidases one <br />                                          (Tb927.5.3220, putative signal peptidase) effect parasite growth (Fig. 1). Most ser- <br />                                          ine peptidase genes targeted individually, multi-target RNAi plasmids de- <br />                                          signed. The tandem array carboxypeptidase genes (Tb927.10.1030, Tb927.10.1040 and <br />                                          Tb927.10.50) share 84% identity, targeted single RNAi fragment. There are <br />                                          highly similar genes S9 serine peptidases. The non-contiguous genes coding <br />                                          oligopeptidase B (OPB), (Tb927.11.12850), OPB-like peptidases (Tb927.7.4940) share <br />                                          40% identity, similar activities and/or function. To overcome possible OPB/ <br />                                          OPB-like redundancy, knock-down construct targeting genes designed. As is <br />                                          insufficient sequence identity target genes single RNAi fragment, construct in- <br />                                          corporating tandem RNAi fragments generated (pTL2078). Similarly two <br />                                          prolyl oligopeptidase (POP)-like genes, Tb927.10.8020 Tb927.5.4300, having 34% identity, <br />                                          simultaneously targeted dual RNAi construct (pTL2079). <br />                                              The cell lines OPB OPB-like genes (Tb927.11.12850 Tb927.7.4940/ <br />                                          Tb11.v5.0175) POP POP-like genes (Tb927.10.8020 Tb927.5.4300) tar- <br />                                          geted displayed growth defect RNAi. The non-essential nature OPB seen our <br />                                          RNAi lines supported observation OPB knock-out cells loss of <br />                                          virulence [25]. <br />                                              To determine correct gene targeted, used quantitative PCR to <br />                                          measure relative levels transcript. In cases bar (Tb927.11.980&#8212;omitted dataset), <br />                                          decrease transcript 24 hours RNAi induction, ranging from <br />                                          20% 90% depletion, average knock 60% (Fig. 1, inset). Antibodies against <br />                                          target serine peptidases&#8212;OPB (Tb927.11.12850) DPP8 (Tb927.10.6940 and <br />                                          Tb927.10.6970)&#8212;were available, used check targeted knock-down the <br />  <br />  <br />  <br /> PLOS ONE | DOI:10.1371/journal.pone.0123241 March 27, 2015                                                                             6 / 15 <br />                                                                                                 An Essential Signal Peptide Peptidase Trypanosoma brucei <br />  <br />  <br />  <br />  <br /> Fig 1. Effect RNAi serine peptidases T. brucei cell growth vitro. Two independent RNAi cell lines induced 1 &#956;gml-1 tetracycline <br /> (open symbols) left untreated (filled symbols). Cells counted 24 hours, diluted 1 x 105 cells ml-1 cumulative cell number <br /> calculated. Insets: Target transcript levels RNAi cell lines. Insets (upper left): Total RNA isolated non-induced (solid bars) tetracycline-induced <br /> (striped bars) cells used make cDNA, used template real time PCR reaction using gene-specific primers (S2 Table). For cell lines <br /> in multiple genes non-identical sequences targeted, PCR results target shown. Results technical replicates are <br /> shown. Insets (lower right): For targets, Western blots lysates control (-) tetracycline induced (+) cells, using RNAi target protein- <br /> specific antibody (upper panel) &#945;-EF1-&#945; (lower panel). <br /> doi:10.1371/journal.pone.0123241.g001 <br />  <br />  <br />  <br />                                                  protein level. Significant knock OPB DPP8 seen 24 hours (Fig. 1 in- <br />                                                  sets), supporting quantitative PCR data. <br />  <br />  <br />                                                  The S9 serine peptidases <br />                                                  While OPB/OPB-like POP/POP-like peptidases appear dispensable parasite se, <br />                                                  investigated peptidases involved host parasite interaction. <br />                                                  Both OPB POP present secretome T. brucei gambiense [26] been <br />                                                  shown active plasma infected rodents [7, 8], influence the <br />                                                  course infection cleavage host peptides bloodstream. To test this, ICR mice were <br />                                                  infected RNAi cell lines targeting OPB/OPB-like genes (Tb927.11.12850 and <br />  <br />  <br />  <br /> PLOS ONE | DOI:10.1371/journal.pone.0123241 March 27, 2015                                                                                                   7 / 15 <br />                                                                                               An Essential Signal Peptide Peptidase Trypanosoma brucei <br />  <br />  <br />  <br />  <br /> Fig 2. Effect RNAi T. brucei cell growth vivo. ICR mice inoculated RNAi cell lines targeting OPB-like genes (a), POP-like <br /> genes (b), dipeptidyl peptidase-8 (c), type-I signal peptidase (d). Two mice experiment left untreated (filled symbols) given <br /> doxycycline (open symbols) induce RNAi. The arrow indicates doxycycline administration. Parasitaemia infected mice counted the <br /> times indicated. <br /> doi:10.1371/journal.pone.0123241.g002 <br />  <br />  <br />  <br />                                                 Tb927.7.4940), POP/POP-like genes (Tb927.10.8020 Tb927.5.4300). Parasitae- <br />                                                 mia infected animals measured 24 48 hours induction RNAi (Fig. 2a b). <br />                                                 At time points, significant difference induced uninduced RNAi <br />                                                 lines pair peptidases. Animals euthanised point, parasiteamia lev- <br />                                                 els rose humane threshold 1 x 108 cells ml-1. These results indicate reduction <br />                                                 OPB/OPB-like POP/POP-like peptidases effect progression infec- <br />                                                 tion mice, individually concert. <br />                                                     We investigated T. brucei dipeptidyl peptidase (DPP8) reasons. Firstly, <br />                                                 member S9 serine peptidase family, includes putative virulence factors such <br />                                                 POP OPB, hypothesised DPP8 host bloodstream affect virulence. In- <br />                                                 deed, related human enzyme DPP IV known cleave, inactivate, circulating <br />                                                 chemokines [27]. Secondly, human DPP IV target type-2 diabetes drugs setting pre- <br />                                                 cedent drugability enzyme. We expressed recombinant enzyme, con- <br />                                                 firmed Pro-specific aminopeptidase, able cleave peptide substrate <br />                                                 H-Gly-Pro-AMC, N-terminally blocked Z-Gly-Pro-AMC (Fig. 3a). We used the <br />  <br />  <br />  <br />  <br /> PLOS ONE | DOI:10.1371/journal.pone.0123241 March 27, 2015                                                                                                8 / 15 <br />                                                                                         An Essential Signal Peptide Peptidase Trypanosoma brucei <br />  <br />  <br />  <br />  <br /> Fig 3. Recombinant TbDPP8 activity inhibition. (a) Rate cleavage TbDPP8 H-Gly-Pro-AMC (grey bars) Z-Gly-Pro-AMC (white bars). (b) <br /> Structures inhibitors used TbDPP8. (c) Inhibitory activity compounds T. brucei DPP8, human DPP IV, human DPP8, bloodstream <br /> form T. brucei 427. <br /> doi:10.1371/journal.pone.0123241.g003 <br />  <br />  <br />  <br />  <br />                                              recombinant DPP8 activity assay test panel potential DPP8 inhibitors: licensed dia- <br />                                              betes drug, vildagliptin, series compounds designed target human DPP IV/8/9 en- <br />                                              zymes [28] (Fig. 3b). T. brucei DPP8 inhibited 40&#8211;60 nM UAMC00374, <br />                                              UAMC00691 vildagliptin (Fig. 3c). These molecules, data inhibitory <br />                                              potency (IC50-values) human DPP IV, DPP8/9, prolyl oligopeptidase, DPP II, fi- <br />                                              broblast activation protein (FAP) reported earlier [19&#8211;23]. The IC50 values the <br />                                              human enzyme presented determined slightly different conditions to <br />                                              published earlier. This accounts slightly different, nonetheless comparable <br />                                              IC50-values. <br />                                                  Nevertheless, compounds relatively ineffective bloodstream form of <br />                                              T. brucei, having EC50 values greater 25&#956;M, suggesting chemical depletion of <br />                                              DPP8 detrimental parasite. The effective trypanocidal compounds <br />                                              (UAMC00701 UAMC00726) poor inhibitors DPP8, highlighting lack <br />                                              correlation trypanocidal activity DPP8 inhibition. The poor trypanocidal activ- <br />                                              ity DPP IV inhibitors consistent result RNAi screen showing effect of <br />                                              DPP8 knock down. In addition, RNAi DPP8 vivo caused change parasitaemia <br />  <br />  <br />  <br /> PLOS ONE | DOI:10.1371/journal.pone.0123241 March 27, 2015                                                                                      9 / 15 <br />                                                                                  An Essential Signal Peptide Peptidase Trypanosoma brucei <br />  <br />  <br />  <br />                                          (Fig. 2c) indicating that, DPP8 does activity host bloodstream, does not <br />                                          affect progression infection. <br />  <br />  <br />                                          Type I signal peptidase <br />                                          While GeneDB lists T. brucei type I signal peptidase (SPP1, Tb927.5.3220) member of <br />                                          E. coli-like S26A sub-family, similar animal type-I signal pep- <br />                                          tidases (S26B sub-family), bearing 33% sequence identity human SEC11c compared with <br />                                          12% E. coli SP-1. In addition, T. brucei SPP1 codes serine/histidine catalytic dyad, a <br />                                          feature S26B peptidases, serine/lysine dyad S26A peptidases [20]. <br />                                              As SPP1 appears serine peptidase necessary T. brucei survival in <br />                                          vitro, examined closely effects depleting gene. Firstly, tested the <br />                                          loss fitness parasites held true vivo. Mice inoculated SPP1 RNAi cell <br />                                          line RNAi induced doxycycline. Parasitaemia doxycycline treated mice <br />                                          dropped 48 hours, undetectable 72 hours (Fig. 2d). The kinetics parasite de- <br />                                          pletion RNAi vivo similar seen vitro. <br />                                              We looked evidence phenotype displayed SPP1 RNAi cell line to <br />                                          off-target transcript depletion, bymeasuring level mitochondrial signal peptidase <br />                                          (mitSP, Tb927.10.4590) induction SPP1 RNAi. The mitSP gene bears 42% identity to <br />                                          SPP1, insufficient local sequence similarity target SPP1 RNAi cell <br />                                          line. Quantitative PCR RNAi SPP1 showed that, despite significant (&gt;80%) reduction <br />                                          SPP1 transcript, mitSP transcript depleted. Indeed, mitSP transcript increased by <br />                                          50% (data shown), possibly reflecting compensation depletion SPP1. <br />                                              In <span id='am-82' about='obo:NCBITaxon_order' typeof='owl:Thing NCBITaxon:_taxonomic_rank'><span id='am-83' property="rdfs:label" content="order" datatype="xsd:string"></span><span id='am-84' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>order</span> verify SPP1 knock-down responsible loss fitness RNAi <br />                                          line, attempted rescue SPP1 RNAi phenotype expressing RNAi-resistant <br />                                          recoded SPP1 gene (SPP1R). SPP1R insufficient sequence identity endogenous <br />                                          SPP1 gene target RNAi machinery leads constitutive expression full <br />                                          length SPP1. We able detect expression SPP1R protein C-terminal HA tag <br />                                          (Fig. 4a). When SPP1 RNAi induced cell line, growth defect (Fig. 4b), <br />                                          indicating cells rescued detrimental RNAi phenotype (Fig. 4c) by <br />                                          functional expression SPP1. To verify RNAi endogenous SPP1 remained functional <br />                                          cells expressing SPP1R, used quantitative PCR. Endogenous SPP1 transcript reduced <br />                                          approximately 85% tetracycline-induced cells, similar knock-down levels seen the <br />                                          parental SPP1 RNAi line (Fig. 4d). This demonstrates normal phenotype cells <br />                                          presence functional SPP1, emergence cells refractory to <br />                                          RNAi. We wanted test ability SPP1R gene restore normal pheno- <br />                                          type putative serine peptidase activity. The active site serine mutated gly- <br />                                          cine, expression mutated SPP1confirmed Western blot (Fig. 4a). Cells expressing <br />                                          catalytically inactive SPP1 displayed growth defect endogenous SPP1 down-regu- <br />                                          lated RNAi (Fig. 4e), similar parental RNAi cell line (Fig. 4c). <br />                                              With aim verifying signal peptidase activity T. brucei SPP1 expressed and <br />                                          purified recombinant forms protein E. coli. A small soluble recombinant <br />                                          protein, lacking predicted N-terminal transmembrane domain carrying N-terminal <br />                                          MBP fusion, purified (not shown). However, unable detect peptidase activity <br />                                          using fluorogenic peptide substrate known cleaved E. coli P. falciparum signal <br />                                          peptidases [29]. We attempted rescue E. coli strains conditionally deficient in <br />                                          endogenous signal peptidase (LepB) [21], expressing SPP1. Although expression either <br />                                          length truncated SPP1 successfully induced conditions LepB repression, <br />                                          insufficient rescue LepB deficient growth defect (not shown). <br />  <br />  <br />  <br /> PLOS ONE | DOI:10.1371/journal.pone.0123241 March 27, 2015                                                                            10 / 15 <br />                                                                                             An Essential Signal Peptide Peptidase Trypanosoma brucei <br />  <br />  <br />  <br />  <br /> Fig 4. Rescue SPP1 RNAi growth defect expression recoded SPPI. (a) Expression recoded HA-tagged SPP1 detected Western blot. Cell <br /> lysates RNAi cell line (-), RNAi cell line expressing SPP1 recoded gene (SPP1R), RNAi cell line expressing inactive SPP1 a <br /> recodedgene (SPP1R,I) probed anti-HA antibody (Roche). Detection EF-1&#945; used loading control. (b, c e) Parasite growth was <br /> measured cell lines inducing SPP1 RNAi tetracycline (open squares) treatment (closed squares) SPP1 RNAi cell line expressing <br /> SPP1 from: recoded gene SPP1R (b), parental SPP1 RNAi cell line (c), RNAi cell line expressing inactive SPP1 recoded gene, SPP1R,I <br /> (e). (d) Quantitative PCR showing relative quantification (RQ) endogenous SPP1 transcript RNAi cell line expressing active SPP1 SPP1R <br /> gene induction (control, black bars) induction tetracycline (+ Tet, white bars). <br /> doi:10.1371/journal.pone.0123241.g004 <br />  <br />  <br />  <br />  <br />                                                Discussion <br />                                                Technical developments, notably improved transfection efficiency [30], expanded the <br />                                                scope RNAi T. brucei, extent genome-wide RNAi screens carried [6, <br />                                                31]. A deficiency screens scale that, measured output loss fitness, <br />                                                clonal cell lines isolated genome-wide pool. Instead, regeneration individual <br />                                                RNAi cell lines carried confirm importance viability identified <br />                                                genes. By exploiting recent developments RNAi T. brucei [5, 17] able to <br />                                                screen complete set serine peptidases T. brucei, followed qPCR validation in- <br />                                                dividual clones. In addition, able extend analysis potentially interesting tar- <br />                                                gets vivo model. <br />                                                   We report 20 serine peptidase genes T. brucei, represent 18 unique <br />                                                coding sequences. While gene, SPP1, emerged screen essential, compari- <br />                                                son genome-wide RNAi screen [6], showed SPP1 revealed RIT-seq <br />                                                method essential (Table 1). In contrast genome screen, able validate <br />                                                RNAi cell lines using quantitative PCR, subsequently follow vitro <br />                                                data vivo experiments. One explanation failure RIT-seq detect SPP1 the <br />  <br />  <br />  <br /> PLOS ONE | DOI:10.1371/journal.pone.0123241 March 27, 2015                                                                                           11 / 15 <br />                                                                                  An Essential Signal Peptide Peptidase Trypanosoma brucei <br />  <br />  <br />  <br />                                          relatively small gene size. At 627bp, SPP1 likely under-represented RNAi library <br />                                          (which reported average &gt;5 targets/CDS), possibly likely fall the <br />                                          threshold significant difference induced uninduced cells. Results three <br />                                          serine peptidases screen correlate RIT-seq data. One the <br />                                          OPB-like gene (Tb927.7.4940) displayed loss fitness bloodstream form cells 3 <br />                                          6 days induction. However, addition dual RNAi OPB/OPB-like cell line, gener- <br />                                          ated RNAi cell line OPB-like gene targeted, displayed no <br />                                          growth defect 4 days (data shown). Altogether, comparison experiments <br />                                          illustrates necessity following large-scale RNAi screens independent validation <br />                                          potentially interesting targets. <br />                                              The S9 serine peptidases OPB POP promoted suitable drug targets [32] <br />                                          based presence host bloodstream, ability cleave host peptides. How- <br />                                          ever, peptidases essential parasite survival, vitro. T. brucei OPB <br />                                          knockout parasites viable virulent wild-type parasites [25]. Similarly, T.cruzi and <br />                                          L. major OPB null parasites viable, albeit compromised ability infect host cells <br />                                          [3, 29]. By generating paired OPB OPB-like RNAi knock-downs, provide supporting <br />                                          evidence OPB non-essential, related OPB-like gene likely <br />                                          essential that, genes overlapping function, insensitive to <br />                                          down-regulation levels achieved screen. We evidence that <br />                                          OPB POP influence parasite survival host mice, capable cleaving <br />                                          host cell peptides, capacity does alter course infection. <br />                                              SPP1 serine peptidase T. brucei demonstrated essential parasite sur- <br />                                          vival. Type-I signal peptidases shown essential bacterial <span id='am-79' about='obo:NCBITaxon_species' typeof='owl:Thing NCBITaxon:_taxonomic_rank'><span id='am-80' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-81' property="rdfs:label" content="species" datatype="xsd:string"></span>species</span> examined <br />                                          date [13], yeast [33]. In <span id='am-43' about='obo:NCBITaxon_5664' typeof='owl:Thing obo:NCBITaxon_1 obo:NCBITaxon_38581 obo:NCBITaxon_131567 obo:NCBITaxon_5658 obo:NCBITaxon_33682 obo:NCBITaxon_1286322 obo:NCBITaxon_5654 obo:NCBITaxon_2759 obo:NCBITaxon_38568 obo:NCBITaxon_5653'><span id='am-44' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-45' property="oboInOwl:hasRelatedSynonym" content="Leishmania (Leishmania) major" datatype="xsd:string"></span><span id='am-46' property="oboInOwl:hasRelatedSynonym" content="Leishmania tropica major" datatype="xsd:string"></span><span id='am-47' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-48'  ></span><span id='am-49' property="rdfs:label" content="Leishmania major" datatype="xsd:string"></span>Leishmania major</span>, SPP1 null mutants generated, <br />                                          suggesting essential function, heterozygote mutants showed reduced infectivity [22]. <br />                                          <span id='am-50' about='obo:NCBITaxon_5820' typeof='owl:Thing obo:NCBITaxon_1 obo:NCBITaxon_5794 obo:NCBITaxon_131567 obo:NCBITaxon_422676 obo:NCBITaxon_2759 obo:NCBITaxon_5819 obo:NCBITaxon_33630'><span id='am-51' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-52'  ></span><span id='am-53' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-54' property="rdfs:label" content="Plasmodium" datatype="xsd:string"></span>Plasmodium</span> falciparum dsRNA targeting type-I signal peptidase inhibited cell growth [29]. <br />                                          There high degree conservation type-I signal peptidase substrates, core <br />                                          A-X-A motif recognised eukaryotic ER bacterial type-I signal peptidases [34]. This sub- <br />                                          strate conservation illustrated vitro cleavage E. coli MBP signal sequence SPP1 <br />                                          <span id='am-55' about='obo:NCBITaxon_5833' typeof='obo:NCBITaxon_5820 owl:Thing obo:NCBITaxon_1 obo:NCBITaxon_5794 obo:NCBITaxon_131567 obo:NCBITaxon_418107 obo:NCBITaxon_422676 obo:NCBITaxon_2759 obo:NCBITaxon_5819 obo:NCBITaxon_33630'><span id='am-56' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-57' property="rdfs:label" content="Plasmodium falciparum" datatype="xsd:string"></span><span id='am-58' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-59' property="oboInOwl:hasExactSynonym" content="malaria parasite P. falciparum" datatype="xsd:string"></span><span id='am-60' property="oboInOwl:hasRelatedSynonym" content="Plasmodium (Laverania) falciparum" datatype="xsd:string"></span><span id='am-61'  ></span>Plasmodium falciparum</span> [29]. Type-I signal peptidases inhibited standard ser- <br />                                          ine protease inhibitors, work gone developing signal peptidase inhibitors as <br />                                          broad spectrum anti-bacterials [19]. The SPP1 inhibitor arylomysin derivatives ef- <br />                                          fective bacteria, spectrum limited natural mutations in <br />                                          SPP1 [35]. The effectiveness arylomicin inhibitors eukaryotic SPP1 is, knowledge, <br />                                          known. As broad spectrum efficacy required treatment HAT, screening these <br />                                          S26A peptidase inhibitors T. brucei advisable approach. <br />                                              We able T. brucei SPP1 active serine peptidase, activity <br />                                          essential parasite survival. The failure detect activity recombinant SPP1 forms may <br />                                          absence signal peptidase complex subunits. A multi-subunit signal pepti- <br />                                          dase complex (SPC) probably present T. brucei, eukaryotic type-I signal pepti- <br />                                          dases complexed non-catalytic subunits [32]. We searched similar <br />                                          non-catalytic signal peptidase complex subunits T. brucei carrying BLASTP searches <br />                                          yeast signal peptidase complex subunits T. brucei genome retrieved one <br />                                          SPC3-like subunit (Tb927.5.1930). The SPC3 subunit essential activity catalytic <br />                                          subunit (Sec11p) yeast [36]. RIT-seq experiments indicate T. brucei SPC-3 like subunit is <br />                                          essential [6], worth investigating gene closely clarify an <br />                                          essential non-catalytic component T. brucei signal peptidase complex. <br />                                              It worth considering suitable SPP1 substrates present T. brucei. The cleav- <br />                                          age motif type-I signal peptidases (A-X-A) conserved species, signal <br />  <br />  <br />  <br /> PLOS ONE | DOI:10.1371/journal.pone.0123241 March 27, 2015                                                                            12 / 15 <br />                                                                                         An Essential Signal Peptide Peptidase Trypanosoma brucei <br />  <br />  <br />  <br />                                          peptide comprises charged n-region hydrophobic h-region [34]. A search T. <br />                                          brucei genome coding sequences containing signal peptide (using SignalP) A-X-A <br />                                          motif amino acids 22&#8211;32 230 genes (excluding pseudogenes) (S3 Table). It be <br />                                          interesting examine processing localisation potential SPP1 sub- <br />                                          strates SPP1 RNAi cell line. On basis data, significant defect ER transit <br />                                          predicted potential substrates. <br />  <br />                                          Supporting Information <br />                                          S1 Table. Primer sequences used amplify RNAi target. <br />                                          (DOCX) <br />                                          S2 Table. Primers used quantitative PCR. <br />                                          (DOCX) <br />                                          S3 Table. Potential SPP1 substrates. <br />                                          (DOCX) <br />                                          S1 Fig. Alignment SPPI recoded SPPI sequences. <br />                                          (DOCX) <br />  <br />  <br />                                          Acknowledgments <br />                                          We thank Jim Scott technical support, Alan Scott protein purification. CXM was <br />                                          supported Beit Memorial Fellowship Medical Research. JCM supported the <br />                                          Medical Research Council grant G0700127. The Wellcome Trust Centre Molecular Parasi- <br />                                          tology supported core funding Wellcome Trust [085349]. <br />  <br />                                          Author Contributions <br />                                          Conceived designed experiments: CXM JCM. Performed experiments: CXM EB <br />                                          AH. Analyzed data: CXM PVdV KA JCM. Contributed reagents/materials/analysis tools: <br />                                          PVdV KA. Wrote paper: CXM PVdV JCM. <br />  <br />                                          References <br />                                           1.   WHO. African trypanosomiasis (sleeping sickness). Fact sheet No. 259. October 2010 2010. <br />                                           2.   Berriman M, Ghedin E, Hertz-Fowler C, Blandin G, Renauld H, Bartholomeu DC, et al. The genome of <br />                                                African trypanosome Trypanosoma brucei. Science. 2005 Jul 15; 309(5733):416&#8211;22. PMID: <br />                                                16020726 <br />                                           3.   Caler EV, Vaena Avalos S, Haynes PA, Andrews NW, Burleigh BA. Oligopeptidase B-dependent <br />                                                signaling mediates host cell invasion Trypanosoma cruzi. The EMBO journal. 1998 Sep 1; 17 <br />                                                (17):4975&#8211;86. Epub 1998/09/02. eng. PMID: 9724634 <br />                                           4.   Subramaniam C, Veazey P, Redmond S, Hayes-Sinclair J, Chambers E, Carrington M, et al. Chromo- <br />                                                some-wide analysis gene function RNA interference african trypanosome. Eukaryot Cell. <br />                                                2006 Sep; 5(9):1539&#8211;49. PMID: 16963636 <br />                                           5.   Jones NG, Thomas EB, Brown E, Dickens NJ, Hammarton TC, Mottram JC. Regulators Trypano- <br />                                                soma brucei cell cycle progression differentiation identified using kinome-wide RNAi screen. <br />                                                PLoS pathogens. 2014 Jan; 10(1):e1003886. Epub 2014/01/24. eng. doi: 10.1371/journal.ppat. <br />                                                1003886 PMID: 24453978 <br />                                           6.   Alsford S, Turner DJ, Obado SO, Sanchez-Flores A, Glover L, Berriman M, et al. High-throughput phe- <br />                                                notyping using parallel sequencing RNA interference targets African trypanosome. Genome <br />                                                Res. 2011 Jun; 21(6):915&#8211;24. doi: 10.1101/gr.115089.110 PMID: 21363968 <br />                                           7.   Morty RE, Lonsdale-Eccles JD, Mentele R, Auerswald EA, Coetzer TH. Trypanosome-derived oligo- <br />                                                peptidase B released plasma infected rodents, persists retains catalytic <br />                                                activity. Infect Immun. 2001 Apr; 69(4):2757&#8211;61. PMID: 11254649 <br />  <br />  <br />  <br />  <br /> PLOS ONE | DOI:10.1371/journal.pone.0123241 March 27, 2015                                                                                          13 / 15 <br />                                                                                        An Essential Signal Peptide Peptidase Trypanosoma brucei <br />  <br />  <br />  <br />                                           8.   Bastos IM, Motta FN, Charneau S, Santana JM, Dubost L, Augustyns K, et al. Prolyl oligopeptidase of <br />                                                Trypanosoma brucei hydrolyzes native collagen, peptide hormones active plasma in- <br />                                                fected mice. Microbes Infect. 2010 Jun; 12(6):457&#8211;66. doi: 10.1016/j.micinf.2010.02.007 PMID: <br />                                                20188209 <br />                                           9.   Bastos IM, Grellier P, Martins NF, Cadavid-Restrepo G, Souza-Ault MR, Augustyns K, et al. Molecu- <br />                                                lar, functional structural properties prolyl oligopeptidase Trypanosoma cruzi (POP Tc80), <br />                                                required parasite entry mammalian cells. Biochem J. 2005 May 15; 388(Pt 1):29&#8211;38. <br />                                                PMID: 15581422 <br />                                          10.   Morty RE, Pelle R, Vadasz I, Uzcanga GL, Seeger W, Bubis J. Oligopeptidase B Trypanosoma <br />                                                evansi. A parasite peptidase inactivates atrial natriuretic factor bloodstream infected <br />                                                hosts. J Biol Chem. 2005 Mar 25; 280(12):10925&#8211;37. PMID: 15644339 <br />                                          11.   Troeberg L, Pike RN, Morty RE, Berry RK, Coetzer TH, Lonsdale-Eccles JD. Proteases Trypano- <br />                                                soma brucei brucei. Purification, characterisation interactions host regulatory molecules. Eur J <br />                                                Biochem. 1996 Jun 15; 238(3):728&#8211;36. PMID: 8706674 <br />                                          12.   Morty RE, Troeberg L, Powers JC, Ono S, Lonsdale-Eccles JD, Coetzer TH. Characterisation the <br />                                                antitrypanosomal activity peptidyl alpha-aminoalkyl phosphonate diphenyl esters. Biochem Pharma- <br />                                                col. 2000 Nov 15; 60(10):1497&#8211;504. PMID: 11020452 <br />                                          13.   Alsford S, Eckert S, Baker N, Glover L, Sanchez-Flores A, Leung KF, et al. High-throughput decoding <br />                                                antitrypanosomal drug efficacy resistance. Nature. 2012 Feb 9; 482(7384):232&#8211;6. Epub 2012/ <br />                                                01/27. eng. doi: 10.1038/nature10771 PMID: 22278056 <br />                                          14.   Russell-Jones D, Gough S. Recent advances incretin-based therapies. Clin Endocrinol (Oxf). 2012 <br />                                                Oct; 77(4):489&#8211;99. doi: 10.1111/j.1365-2265.2012.04483.x PMID: 22804841 <br />                                          15.   Rawlings ND, Waller M, Barrett AJ, Bateman A. MEROPS: database proteolytic enzymes, their <br />                                                substrates inhibitors. Nucleic Acids Res. 2014 Jan; 42(Database issue):D503&#8211;9. Epub 2013/10/ <br />                                                26. eng. doi: 10.1093/nar/gkt953 PMID: 24157837 <br />                                          16.   Santos JM, Graindorge A, Soldati-Favre D. New insights parasite rhomboid proteases. Mol Bio- <br />                                                chem Parasitol. 2012 Mar-Apr; 182(1&#8211;2):27&#8211;36. doi: 10.1016/j.molbiopara.2011.12.005 PMID: <br />                                                22240114 <br />                                          17.   Alsford S, Horn D. Single-locus targeting constructs reliable regulated RNAi transgene expres- <br />                                                sion Trypanosoma brucei. Mol Biochem Parasitol. 2008 Sep; 161(1):76&#8211;9. Epub 2008/07/01. eng. <br />                                                doi: 10.1016/j.molbiopara.2008.05.006 PMID: 18588918 <br />                                          18.   Redmond S, Vadivelu J, Field MC. RNAit: automated web-based tool selection RNAi tar- <br />                                                gets Trypanosoma brucei. Mol Biochem Parasitol. 2003 Apr 25; 128(1):115&#8211;8. PMID: 12706807 <br />                                          19.   Van der Veken P, De Meester I, Dubois V, Soroka A, Van Goethem S, Maes MB, et al. Inhibitors of <br />                                                dipeptidyl peptidase 8 dipeptidyl peptidase 9. Part 1: identification dipeptide derived leads. <br />                                                Bioorg Med Chem Lett. 2008 Jul 15; 18(14):4154&#8211;8. Epub 2008/06/17. eng. doi: 10.1016/j.bmcl.2008. <br />                                                05.080 PMID: 18556199 <br />                                          20.   Van Goethem S, Van der Veken P, Dubois V, Soroka A, Lambeir AM, Chen X, et al. Inhibitors dipepti- <br />                                                dyl peptidase 8 dipeptidyl peptidase 9. Part 2: isoindoline containing inhibitors. Bioorg Med Chem <br />                                                Lett. 2008 Jul 15; 18(14):4159&#8211;62. Epub 2008/06/17. eng. doi: 10.1016/j.bmcl.2008.05.079 PMID: <br />                                                18556198 <br />                                          21.   Van Goethem S, Matheeussen V, Joossens J, Lambeir AM, Chen X, De Meester I, et al. Structure-ac- <br />                                                tivity relationship studies isoindoline inhibitors dipeptidyl peptidases 8 9 (DPP8, DPP9): is <br />                                                DPP8-selectivity attainable goal? Journal medicinal chemistry. 2011 Aug 25; 54(16):5737&#8211;46. <br />                                                Epub 2011/06/30. eng. doi: 10.1021/jm200383j PMID: 21711053 <br />                                          22.   Van der Veken P, Haemers A, Augustyns K. Prolyl peptidases related dipeptidyl peptidase IV: poten- <br />                                                tial specific inhibitors drug discovery. Current topics medicinal chemistry. 2007; 7(6):621&#8211;35. <br />                                                Epub 2007/03/14. eng. PMID: 17352682 <br />                                          23.   Villhauer EB, Brinkman JA, Naderi GB, Burkey BF, Dunning BE, Prasad K, et al. 1-[[(3-hydroxy-1-<span id='am-62' about='obo:NCBITaxon_125078' typeof='owl:Thing obo:NCBITaxon_78536 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_4447 obo:NCBITaxon_4747 obo:NCBITaxon_3398 obo:NCBITaxon_1437183 obo:NCBITaxon_33090 obo:NCBITaxon_158332 obo:NCBITaxon_73496 obo:NCBITaxon_131221 obo:NCBITaxon_58024 obo:NCBITaxon_58023 obo:NCBITaxon_158418 obo:NCBITaxon_2759 obo:NCBITaxon_158394 obo:NCBITaxon_35493 obo:NCBITaxon_1437197 obo:NCBITaxon_3193'><span id='am-63' property="rdfs:label" content="Ada" datatype="xsd:string"></span><span id='am-64' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-65' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-66'  ></span><span id='am-67' property="oboInOwl:hasRelatedSynonym" content="Ada Lindl." datatype="xsd:string"></span>ada</span>- <br />                                                mantyl)amino]acetyl]-2-cyano-(S)-pyrrolidine: potent, selective, orally bioavailable dipeptidyl <br />                                                peptidase IV inhibitor antihyperglycemic properties. Journal medicinal chemistry. 2003 Jun 19; <br />                                                46(13):2774&#8211;89. Epub 2003/06/13. eng. PMID: 12801240 <br />                                          24.   Durand-Dubief M, Kohl L, Bastin P. Efficiency specificity RNA interference generated intra- <br />                                                intermolecular double stranded RNA Trypanosoma brucei. Molecular Biochemical Parasitol- <br />                                                ogy. 2003 6//; 129(1):11&#8211;21. PMID: 12798502 <br />                                          25.   Kangethe RT, Boulange AF, Coustou V, Baltz T, Coetzer TH. <span id='am-14' about='obo:NCBITaxon_5702' typeof='owl:Thing obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_39700 obo:NCBITaxon_33682 obo:NCBITaxon_5654 obo:NCBITaxon_5690 obo:NCBITaxon_2759 obo:NCBITaxon_5691 obo:NCBITaxon_5653'><span id='am-15' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-16' property="oboInOwl:hasRelatedSynonym" content="Trypanosoma (Trypanozoon) brucei brucei" datatype="xsd:string"></span><span id='am-17' property="rdfs:label" content="Trypanosoma brucei brucei" datatype="xsd:string"></span><span id='am-18' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-19'  ></span>Trypanosoma brucei brucei</span> oligopepti- <br />                                                dase B null mutants display increased prolyl oligopeptidase-like activity. Mol Biochem Parasitol. 2012 <br />                                                Mar-Apr; 182(1&#65533; <br /> </body></html>